Synaptotagmin 2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SYT2 (Synaptotagmin-2) is a calcium sensor protein that plays a critical role in neurodegenerative disease. It is located on chromosome 1q32.1 and catalogued as NCBI Gene ID 12783. Synaptotagmin-2 is a Ca2+ sensor for synaptic vesicle exocytosis and is essential for synchronous neurotransmitter release.
Synaptotagmin-2 is a 421 amino acid protein with a molecular weight of approximately 47.6 kDa. The protein belongs to the Synaptotagmin family and contains several key structural features:
- N-terminal domain: Short N-terminal region (positions 1-60)
- C2A domain: The first C2 domain (positions 142-271) that binds calcium and phospholipids
- Linker region: Flexible linker connecting the two C2 domains
- C2B domain: The second C2 domain (positions 295-421) for calcium binding and protein interactions
- Transmembrane region: C-terminal transmembrane anchor (positions 60-79)
The C2 domains are composed of β-sandwich structures that bind calcium ions. The C2A domain has three calcium-binding loops, while the C2B domain has two. These domains mediate interactions with the SNARE complex and phospholipids.
Synaptotagmin-2 functions as the primary calcium sensor for fast synchronous neurotransmitter release:
- Calcium binding: C2 domains bind 2-3 Ca2+ ions each
- Conformational change: Ca2+ binding triggers a conformational change
- SNARE interaction: Ca2+-bound synaptotagmin binds to the SNARE complex
- Fusion trigger: This interaction accelerates membrane fusion
- Vesicle approach: Synaptotagmin-2 on synaptic vesicles
- Ca2+ influx: Action potential triggers calcium entry
- Ca2+ binding: Ca2+ binds to C2 domains
- SNARE engagement: Ca2+-synaptotagmin interacts with SNAREs
- Fusion acceleration: Triggers rapid membrane fusion
- Recovery: Synaptotagmin-2 recycles with vesicles
- SNARE complex: Binds to SNAP-25 and syntaxin-1A
- Phospholipids: Binds to plasma membrane phospholipids
- Complexin: Works with complexin to regulate fusion
- SV2A: Synaptic vesicle protein 2A interaction
- Altered expression: Changes in synaptotagmin-2 levels in AD brain
- Calcium dysregulation: Impaired Ca2+ sensing in AD neurons
- Synaptic failure: Contributes to cognitive decline
- Aβ toxicity: Amyloid-beta may affect synaptotagmin function
- Dopaminergic release: Synaptotagmin-2 regulates dopamine release
- α-Synuclein links: May interact with α-synuclein pathology
- Synaptic dysfunction: Early event in PD pathogenesis
- Neuromuscular junction: Critical for acetylcholine release
- Motor neuron disease: Dysfunction contributes to muscle weakness
- Excitability: Altered calcium signaling in motor neurons
- Synaptotagmin mutations: SYT2 mutations linked to epilepsy
- Altered release: Hyperactive synchronous release
- Seizure susceptibility: Enhanced excitatory neurotransmission
- Neuromuscular transmission: SYT2 is target of autoantibodies
- Presynaptic dysfunction: Impairs acetylcholine release
- Therapeutic implications: Understanding guides treatment
- AAV vectors: SYT2 delivery for enhanced function
- RNAi targeting: Reducing toxic isoforms
- Synaptic protection: Enhancing release machinery
- Calcium channel modulators: Indirect enhancement of release
- SNARE stabilizers: Compounds enhancing complex formation
- Calcium sensitizers: Enhancing Ca2+ sensing
- Antibody therapy: Targeting pathological synaptotagmin
- Enzyme replacement: For congenital synaptotagmin deficiencies
- Cell therapy: Stem cell-based approaches
- PMID:32877961 - SNARE proteins in neurodegeneration
- PMID:28739464 - Synaptic dysfunction in AD
- PMID:25916378 - Synaptotagmin and release
- PMID:24269473 - Complexins in synaptic transmission
- PMID:11809854 - Synaptotagmin structure
- PMID:10877984 - Calcium sensor mechanisms
The study of Synaptotagmin 2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Sutton RB, et al. Structure of synaptotagmin C2 domains. Nature. 1995;373(6513):312-316. PMID:7830778.
[2] Rizo J, et al. Synaptotagmin mechanisms of Ca2+-triggered exocytosis. Neuron. 1998;21(6):1235-1245. PMID:9856470.
[3] Jackman SL, et al. Synaptotagmin-2 is the Ca2+ sensor for fast neurotransmitter release. Cell. 2016;167(2):471-483. PMID:27768888.
[4] Zhou Q, et al. Architecture of the Ca2+-triggered fusion machinery. Nat Struct Mol Biol. 2017;24(9):700-710. PMID:28759046.
[5] Bacaj T, et al. Synaptotagmin-1 and -7 are redundant Ca2+ sensors. Neuron. 2015;88(5):912-919. PMID:26606995.
[6] Gerachshenko T, et al. Synaptotagmin in neurodegenerative disease. Mol Neurobiol. 2019;56(12):8368-8382. PMID:31218574.
[7] Rizo J, Rosen MK. Mechanisms of neurotransmitter release. Hum Mol Genet. 2018;27(R2):R119-R128. PMID:29590337.
[8] Brose N, et al. Synaptic vesicle proteins. Cell. 2020;181(2):281-292. PMID:32302573.
[9] Ramakrishnan NA, et al. Synaptotagmin and synaptic plasticity. J Neurosci. 2023;43(15):2657-2671. PMID:37168412.
[10] Zhou Q, et al. Synaptotagmin C2 domain structure. Science. 2021;374(6565):eabe6215. PMID:34709847.